KRAS and cancer: Glutamine is considered as a conditional essential amino acid for proliferation and survival of cancer cells.11, 12, 13 In particular, KRAS‐mutated cancer cells are reported to be prone to increase the demand of glutamine.14 Indeed, several studies demonstrated the effects of oncogenic KRAS on glutamine metabolism.